2017
DOI: 10.1016/j.foodres.2017.07.017
|View full text |Cite
|
Sign up to set email alerts
|

The silymarin composition… and why does it matter???

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

5
98
1
6

Year Published

2018
2018
2023
2023

Publication Types

Select...
8

Relationship

3
5

Authors

Journals

citations
Cited by 119 publications
(110 citation statements)
references
References 84 publications
5
98
1
6
Order By: Relevance
“…This is in contrast with the theoretical O–H bond dissociation enthalpies, which are almost the same for both diastereomers [20]. In addition, our results show that the antioxidant/antiradical activities of both sulfated and parent [5] flavonolignans are lower than that of the flavanonol taxifolin (for DPPH scavenging, IC 50 = 6–10 µM) [24,25], which accounts for up to 5% in various silymarin preparations [26]. …”
Section: Resultscontrasting
confidence: 73%
“…This is in contrast with the theoretical O–H bond dissociation enthalpies, which are almost the same for both diastereomers [20]. In addition, our results show that the antioxidant/antiradical activities of both sulfated and parent [5] flavonolignans are lower than that of the flavanonol taxifolin (for DPPH scavenging, IC 50 = 6–10 µM) [24,25], which accounts for up to 5% in various silymarin preparations [26]. …”
Section: Resultscontrasting
confidence: 73%
“…The main characteristic of all the populations, except those from Spata (P2) and Kastoria (P17), was the substantial amount of isosilybin (A and B), with values between 25 and 40% of the total flavonolignan content in silymarin. Although the biological activity of silymarin is often assigned to silybin A and silybin B (Chambers et al, ), some reports support the contribution of other flavonolignans to the beneficial effects of silymarin. According to Deep, Oberlies, Kroll, and Agarwal (), isosilybin B is a valuable agent against prostate cancer, while Davis‐Searles et al () have identified the important roles of both isosilybin A and B as inhibitors of prostate carcinoma growth.…”
Section: Discussionmentioning
confidence: 99%
“…is an annual or biennial species belonging to the Asteraceae family; it is a common weed found in winter cereal fields, roadsides and undisturbed areas in the Mediterranean basin and other European regions (Andrzejewska, Martinelli, & Sadowska, ; Andrzejewska, Sadowska, & Mielcarek, ; Karkanis, Efthimadou, & Bilalis, ; Martinelli, Andrzejewska, Salis, & Sulas, ). Milk thistle seed (botanically correct: fruits) extracts, as well as their constituents, exhibit several medicinal properties (Abenavoli, Capasso, Milic, & Capasso, ; Chambers et al, ; Karkanis et al, ). The pharmacological activity of the seed extracts is because of silymarin, an extract containing the flavonoid taxifolin and several flavonolignans, including silybin A and B, isosilybin A and B, silychristin, isosilychristin and silydianin (Chambers et al, ; Kroll, Shaw, & Oberlies, ).…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…The main active substance found in milk thistle is silymarin (a mixture of at least four closely related flavonolignans), which has been documented to be a hepatoprotective compound. Silymarin is a mixture of silybin A and B (approximately 50–60%), silydianin (about 10%), silychristin (about 20%) and isosilybin A and B (about 5%) (Abenavoli et al ., ; Karkanis et al ., ; Chambers et al ., ). The flavonolignans of silymarin exhibit numerous biological activities such as antioxidant, anti‐inflammatory and immunomodulatory effects.…”
Section: Introductionmentioning
confidence: 97%